Horizontal transmissible protection against myxomatosis and rabbit hemorrhagic disease by using a recombinant myxoma virus

Journal of Virology

Volumn 74, Issue 3, 2000, Pages 1114-1123

  Bárcena, Juan ^a   Morales, Mónica ^a   Vázquez, Belén ^a   Boga, José A ^b   Parra, Francisco ^b   Lucientes, Javier ^c   Pagès Manté, Albert ^d   Sánchez Vizcaíno, José M ^a   Blasco, Rafael ^a   Torres, Juan M ^a  

^a Ctro de Invest en Sanidad Animal   (Spain)

^b UNIVERSITY OF OVIEDO   (Spain)

^c UNIVERSIDAD DE ZARAGOZA   (Spain)

^d LABORATORIOS HIPRA S A   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CAPSID PROTEIN; EPITOPE; VIRUS NUCLEOPROTEIN; VIRUS VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ARTICLE; BLEEDING DISORDER; CONTROLLED STUDY; CORONAVIRUS; FLEA; IMMUNIZATION; INOCULATION; MYXOMATOSIS; NONHUMAN; POXVIRUS; PRIORITY JOURNAL; RABBIT; VIRUS ATTENUATION; VIRUS RECOMBINANT; VIRUS TRANSMISSION; VIRUS VIRULENCE;

ANIMALS; ANTIBODIES, VIRAL; CALICIVIRIDAE INFECTIONS; DISEASE TRANSMISSION, HORIZONTAL; FLEAS; GENETIC VECTORS; HEMORRHAGIC DISEASE VIRUS, RABBIT; MYXOMA VIRUS; MYXOMATOSIS, INFECTIOUS; RABBITS; RECOMBINATION, GENETIC; VACCINATION; VACCINES, SYNTHETIC; VIRAL STRUCTURAL PROTEINS; VIRAL VACCINES;

EID: 0342751308     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.74.3.1114-1123.2000     Document Type: Article

References (63)

1. Argüello, J. L. 1986. Contribución a la profilaxis de la mixomatosis del conejo mediante el uso de una cepa homóloga. Med. Vet. 3:91-103.
2. Argüello, J. L. 1991. Viral haemorrhagic disease of rabbits: vaccination and immune response. Rev. Sci. Tech. Off. Int. Epiz. 10:471-480.
3. Bárcena, J., and R. Blasco. 1998. Recombinant swinepox virus expressing β-galactosidase: investigation of viral host range and gene expression levels in cell culture. Virology 243:396-405.
4. Baŕcena, J., A. Pagès-Manté, R. March, M. Morales, M. A. Ramírez, J. M. Sánchez-Vizcaíno, and J. M. Torres. Isolation of an attenuated myxoma virus field strain that can confer protection against myxomatosis on contacts of vaccinates. Arch. Virol., in press.
5. Bertagnoli, S., J. Gelfi, G. Gall, E. Boilletot, J. F. Vautherot, D. Rasschaert, S. Laurent, F. Petit, C. Boucraut-Baralon, and A. Milon. 1996. Protection against myxomatosis and rabbit viral hemorrhagic disease with recombinant myxoma viruses expressing rabbit hemorrhagic disease virus capsid protein. J. Virol. 70:5061-5066.
6. Bertagnoli, S., J. Gelfi, F. Petit, J. F. Vautherot, D. Rasschaert, S. Laurent, G. Gall, E. Boilletot, J. Chantal, and C. Boucraut-Baralon. 1996. Protection of rabbits against rabbit viral haemorrhagic disease with a vaccinia-RHDV recombinant virus. Vaccine 14:506-510.
7. Blasco, R., N. B. Cole, and B. Moss. 1991. Sequence analysis, expression, and deletion of a vaccinia virus gene encoding a homolog of profilin, a eukaryotic actin-binding protein. J. Virol. 65:4598-4608.
8. Blasco, R., and B. Moss. 1995. Selection of recombinant vaccinia viruses on the basis of plaque formation. Gene 158:157-162.
9. Boga, J. A., R. Casais, M. S. Marín, J. M. Martín-Alonso, R. S. Cármenes, M. Prieto, and F. Parra. 1994. Molecular cloning, sequencing and expression in Escherichia coli of the capsid protein gene from rabbit haemorrhagic disease virus (Spanish isolate AST/89). J. Gen. Virol. 75:2409-2413.
10. Boga, J. A., J. M. Martín-Alonso, R. Casais, and F. Parra. 1997. A single dose immunization with rabbit haemorrhagic disease virus major capsid protein produced in Saccharomyces cerevisiae induces protection. J. Gen. Virol. 78:2315-2318.
11. Brochier, B., M. F. Aubert, P. P. Pastoret, E. Masson, J. Schon, M. Lombard, G. Chappuis, B. Languet, and P. Desmettre. 1996. Field use of a vaccinia-rabies recombinant vaccine for the control of sylvatic rabies in Europe and North America. Rev. Sci. Tech. Off. Int. Epizoot. 15:947-970.
12. Buller, R. M. L., G. L. Smith, K. Cremer, A. L. Notkins, and B. Moss. 1985. Decreased virulence of recombinant vaccinia virus expression vectors is associated with a thymidine kinase-negative phenotype. Nature (London) 317:813-815.
13. Castañón, S., M. S. Marín, J. M. Martín-Alonso, J. A. Boga, R. Casais, J. M. Humara, R. J. Ordás, and F. Parra. 1999. Immunization with potato plants expressing VP60 protein protects against rabbit hemorrhagic disease virus. J. Virol. 73:4452-4455.
14. Chasey, D. 1997. Rabbit haemorrhagic disease: the new scourge of Oryctolagus cuniculus. Lab. Anim. 31:33-44.
15. Cooke, B. D. 1990. Notes on the comparative reproductive biology and the laboratory breeding of the rabbit flea Xenopsylla cunicularis Smit (Siphonaptera: Pulicidae). Aust. J. Zool. 38:527-534.
16. de la Peña, P., and M. Zasloff. 1987. Enhancement of mRNA nuclear transport by promoter elements. Cell 50:613-619.
17. Earl, P. L., and B. Moss. 1991. Generation of recombinant vaccinia viruses, p. 16.17.1-16.17.16. In F. M. Ausubel, R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.), Current protocols in molecular biology. Greene Publishing Associates and Wiley Interscience, New York, N.Y.
18. Falkner, F. G., and B. Moss. 1990. Transient dominant selection of recombinant vaccinia viruses. J. Virol. 64:3108-3111.
19. Fenner, F., and F. N. Ratcliffe. 1965. Myxomatosis. Cambridge University Press, Cambridge, England.
20. Fenner, F., and J. Ross. 1994. Myxomatosis, p. 205-240. In H. V. Thompson and C. M. King (ed.), The European rabbit. The history and biology of a successful colonizer. Oxford University Press, Oxford, England.
21. Fischer, L., F. X. Le Gros, P. W. Mason, and E. Paoletti. 1997. A recombinant canarypox virus protects rabbits against a lethal rabbit hemorrhagic disease virus (RHDV) challenge. Vaccine 15:90-96.
22. Hu, L., J. J. Esposito, and F. W. Scott. 1996. Raccoon poxvirus feline panleukopenia virus VP2 recombinant protects cats against FPV challenge. Virology 218:248-252.
23. Jackson, R. J., and H. G. Bults. 1992. The myxoma virus thymidine kinase gene: sequence and transcriptional mapping. J. Gen. Virol. 73:323-328.
24. Jackson, R. J., and H. G. Bults. 1992. A myxoma virus intergenic transient dominant selection vector. J. Gen. Virol. 73:3241-3245.
25. Jackson, R. J., D. F. Hall, and P. J. Kerr. 1996. Construction of recombinant myxoma viruses expressing foreign genes from different intergenic sites without associated attenuation. J. Gen. Virol. 77:1569-1575.
26. Jiménez, G., I. Correa, M. P. Melgosa, M. J. Bullido, and L. Enjuanes. 1986. Critical epitopes in transmissible gastroenteritis virus neutralization. J. Virol. 64:6270-6273.
27. Kerr, P. J., and S. M. Best. 1998. Myxoma virus in rabbits. Rev. Sci. Tech. Off. Int. Epizoot. 17:256-268.
28. Kerr, P. J., and R. J. Jackson. 1995. Myxoma virus as a vaccine vector for rabbits: antibody levels to influenza virus haemagglutinin presented by a recombinant myxoma virus. Vaccine 13:1722-1726.
29. Laurent, S., J. F. Vautherot, M. F. Madelaine, G. Le Gall, and D. Rasschaert. 1994. Recombinant rabbit hemorrhagic disease virus capsid protein expressed in baculovirus self-assembles into viruslike particles and induces protection. J. Virol. 68:6794-6798.
30. Le Gall, G., C. Arnauld, E. Boilletot, J. P. Morisse, and D. Rasschaert. 1998. Molecular epidemiology of rabbit haemorrhagic disease virus outbreaks in France during 1988-1995. J. Gen. Virol. 79:11-16.
31. Liu, S. J., H. P. Xue, B. Q. Pu, and S. H. Qian. 1984. A new viral disease in rabbits. Anim. Husb. Vet. Med. 16:253-255.
32. Marchandeau, S., J. Chantal, Y. Portejoie, S. Barraud, and Y. Chaval. 1998. Impact of viral hemorrhagic disease on a wild population of European rabbits in France. J. Wildl. Dis. 34:429-435.
33. Marín, M. S., J. M. Martín-Alonso, L. I. Perez-Ordoyo, J. A. Boga, J. L. Argüello-Villares, R. Casais, K. Venugopal, W. Jiang, E. A. Gould, and F. Parra. 1995. Immunogenic properties of rabbit haemorrhagic disease virus structural protein VP60 expressed by a recombinant baculovirus: an efficient vaccine. Virus Res. 39:119-128.
34. Martín-Alonso, J. M., M. Balbin, D. J. Garwes, L. Enjuanes, S. Gascón, and F. Parra. 1992. Antigenic structure of transmissible gastroenteritis virus nucleoprotein. Virology 188:168-174.
35. Matsuura, Y., R. D. Posee, H. A. Overton, and D. H. L. Bishop. 1987. Baculovirus expression vectors: the requirements for high level expression of proteins, including glycoproteins. J. Gen. Virol. 68:1233-1250.
36. Mellor, J., M. J. Dobson, N. A. Roberts, M. F. Tuite, J. S. Emtage, S. White, P. A. Lowe, T. Patel, A. J. Kingsman, and S. M. Kingsman. 1983. Efficient synthesis of enzymatically active calf chymosin in Saccharomyces cerevisiae. Gene 24:1-14.
37. Messud-Petit, F., J. Gelfi, M. Delverdier, M. F. Amardeilh, R. Py, G. Sutter, and S. Bertagnoli. 1998. Serp2, an inhibitor of the interleukin-1β-converting enzyme, is critical in the pathobiology of myxoma virus. J. Virol. 72:7830-7839.
38. Morise, J. P., G. Le Gall, and E. Boilleot. 1991. Hepatitis of viral origin in leporidae: introduction and aetiological hypotheses. Rev. Sci. Tech. Off. Int. Epizoot. 10:283-295.
39. Moss, B. 1996. Genetically engineered poxviruses for recombinant gene expression, vaccination, and safety. Proc. Natl. Acad. Sci. USA 93:11341-11348.
40. Murphy, F. A., C. M. Fauquet, D. H. L. Bishop, S. A. Ghabrial, A. W. Jarvis, G. P. Martelli, M. A. Mayo, and M. D. Summers (ed.). 1995. Virus taxonomy: classification and nomenclature of viruses. Sixth report of the International Committee for the Taxonomy of Viruses. Archives of Virology, Suppl. 10. Springer Verlag, Vienna, Austria.
41. Mutze, G., B. Cooke, and P. Alexander. 1998. The initial impact of rabbit hemorrhagic disease on European rabbit populations in South Australia. J. Wildl. Dis. 34:221-227.
42. Nagesha, H. S., L. F. Wang, A. D. Hyatt, C. J. Morrissy, C. Lenghaus, and H. A. Westbury. 1995. Self-assembly, antigenicity, and immunogenicity of the rabbit haemorhagic disease virus (Czechoslovakian strain V-351) capsid protein expressed in baculovirus. Arch. Virol. 140:1095-1108.
43. Nowotny, N., C. Ros-Bascunana, A. Ballagi-Pordany, D. Gavier-Widen, M. Uhlén, and S. Belak. 1997. Phylogenetic analysis of rabbit haemorrhagic disease and European brown hare syndrome viruses by comparison of sequences from the capsid protein gene. Arch. Virol. 142:657-673.
44. Ohlinger, V. F., B. Haas, G. Meyers, F. Weiland, and H. J. Thiel. 1990. Identification and characterization of the virus causing rabbit hemorrhagic disease. J. Virol. 64:3331-3336.
45. Ohlinger, V. F., and H. J. Thiel. 1993. Rabbit hemorrhagic disease (RHD): characterization of the causative calicivirus. Vet. Res. 24:103-116.
46. Opgenorth, A., K. A. Graham, N. Nation, D. Strayer, and G. McFadden. 1992. Deletion analysis of two tandemly arranged virulence genes in myxoma virus: M11L and myxoma growth factor. J. Virol. 66:4720-4731.
47. Pagès, A., and L. Costa. 1990. Control de la enfermedad hemorrágica vírica del conejo (RHDV) mediante vacunación. Med. Vet. 7:93-96.
48. Pagès, A., and E. Espuña. 1988. Estudios sobre la aplicación de vacunas homólogas de mixomatosis en conejos silvestres. Med. Vet. 5:365-374.
49. Parra, F., and M. Prieto. 1990. Purification and characterization of a calicivirus as the causative agent of a lethal hemorrhagic disease in rabbits. J. Virol. 64:4013-4015.
50. Petit, F., C. Boucraut-Baralon, R. Py, and S. Bertagnoli. 1996. Analysis of myxoma virus genome using pulsed-field gel electrophoresis. Vet. Microbiol. 50:27-32.
51. Plana-Duran, J., M. Bastons, M. J. Rodriguez, I. Climent, E. Cortés, C. Vela, and I. Casal. 1996. Oral immunization of rabbits with VP60 particles confers protection against rabbit hemorrhagic disease. Arch. Virol. 141:1423-1436.
52. Pringle, C. R. 1998. Virus taxonomy - San Diego 1998. Arch. Virol. 143: 1449-1459.
53. Robinson, A. J., R. Jackson, P. Kerr, J. Merchant, I. Parer, and R. Pech. 1997. Progress towards using recombinant myxoma virus as a vector for fertility control in rabbits. Reprod. Fertil. Dev. 9:77-83.
54. Romero, C. H., T. Barrett, R. W. Chamberlain, R. P. Kitching, M. Fleming, and D. N. Black. 1994. Recombinant capripoxvirus expressing the hemagglutinin protein gene of rinderpest virus: protection of cattle against rinderpest and lumpy skin disease viruses. Virology 204:425-429.
55. Saito, J. K., D. G. McKercher, and G. Castrucci. 1964. Attenuation of the myxoma virus and use of the living attenuated virus as an immunizing agent for myxomatosis. J. Infect. Dis. 114:417-427.
56. Saurat, P., Y. Gilbert, and J. P. Ganière. 1978. Etude d'une souche de virus myxomateux modifie. Rev. Med. Vet. 129:415-451.
57. Sibilia, M., M. B. Boniotti, P. Angoscini, L. Capucci, and C. Rossi. 1995. Two independent pathways of expression lead to self-assembly of the rabbit hemorrhagic disease virus capsid protein. J. Virol. 69:5812-5815.
58. Trout, R. C., J. Ross, A. M. Tittensor, and A. P. Fox. 1993. The effect on a British wild rabbit population (Oryctolagus cuniculus) of manipulating myxomatosis. J. Appl. Ecol. 29:679-686.
59. Van der Leek, M. L., J. A. Feller, G. Sorensen, W. Isaacson, C. L. Adams, D. J. Borde, N. Pfeiffer, T. Tran, R. W. Moyer, and E. P. J. Gibbs. 1994. Evaluation of swinepox virus as a vaccine vector in pigs using an Aujeszky's disease (pseudorabies) virus gene insert coding for glycoproteins gp50 and gp63. Vet. Rec. 134:13-18.
60. Villafuerte, R., C. Calvete, J. C. Blanco, and J. Lucientes. 1995. Incidence of viral hemorrhagic disease in wild rabbit populations in Spain. Mammalia 59:651-659.
61. Villafuerte, R., C. Calvete, Z. Górtazar, and S. Moreno. 1994. First epizootic of rabbit hemorrhagic disease in free-living populations of Oryctolagus cuniculus at Doñana National Park, S. W. Spain. J. Wildl. Dis. 30:176-179.
62. Williams, K., I. Parer, B. Coman, J. Burley, and M. Braysher. 1995. Managing vertebrate pests: rabbits. Bureau of Resource Sciences/CSIRO Division of Wildlife and Ecology, Australian Government Publishing Service, Canberra, Australia.
63. Wirblich, C., H. J. Thiel, and G. Meyers. 1996. Genetic map of the calicivirus rabbit hemorrhagic disease virus as deduced from in vitro translation studies. J. Virol. 70:7974-7983.